跳至主要内容
临床试验/ISRCTN73359806
ISRCTN73359806已完成不适用

A prospective randomised, double-masked clinical trial comparing bevacizumab to ranibizumab in age-related macular degeneration

VA Boston Healthcare System (USA)0 个研究点目标入组 125 人开始时间: 2009年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
125

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Exudative AMD involving the foveal centre confirmed by intravenous fluorescein angiography
  • 2. Aged greater than 50 years, either sex
  • 3. Ability to provide informed consent

排除标准

  • 1. Previous treatment for exudative AMD in the past one year
  • 2. Presence of subretinal haemorrhage that is greater than 50% of the size of the lesion
  • 3. Advanced glaucoma
  • 4. Any co-existing macular disease causing decreased vision
  • 5. Uncontrolled hypertension
  • 6. History of thromboembolic phenomenon
  • 7. Participation in another concurrent ophthalmic trial

研究者

发起方
VA Boston Healthcare System (USA)

相似试验